Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement ; volume:101 ; number:2 ; day:2 ; month:12 ; year:2021 ; pages:297-307 ; date:2.2022
Annals of hematology ; 101, Heft 2 (2.12.2021), 297-307, 2.2022
- Urheber
-
Di Giacomo, Danika
Quintini, Martina
Pierini, Valentina
Pellanera, Fabrizia
La Starza, Roberta
Gorello, Paolo
Matteucci, Caterina
Crescenzi, Barbara
Fiumara, Paolo Fabio
Veltroni, Marinella
Borlenghi, Erika
Albano, Francesco
Forghieri, Fabio
Maccaferri, Monica
Bettelli, Francesca
Luppi, Mario
Cuneo, Antonio
Rossi, Giuseppe
Mecucci, Cristina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-021-04712-8
- URN
-
urn:nbn:de:101:1-2022042415115617499523
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Di Giacomo, Danika
- Quintini, Martina
- Pierini, Valentina
- Pellanera, Fabrizia
- La Starza, Roberta
- Gorello, Paolo
- Matteucci, Caterina
- Crescenzi, Barbara
- Fiumara, Paolo Fabio
- Veltroni, Marinella
- Borlenghi, Erika
- Albano, Francesco
- Forghieri, Fabio
- Maccaferri, Monica
- Bettelli, Francesca
- Luppi, Mario
- Cuneo, Antonio
- Rossi, Giuseppe
- Mecucci, Cristina
- SpringerLink (Online service)
Ähnliche Objekte (12)
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
GATA2 deficiency and related myeloid neoplasms
Progression in Myeloid Neoplasms: Beyond the Myeloblast
Landscape of biallelic DNMT3A mutant myeloid neoplasms
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
Spitzoid Neoplasms: Suggestions from Genomic Aberrations
Current Challenges in the Characterization of Myeloid Neoplasms
Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasms
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
Formation of ultralong DH regions through genomic rearrangement
Outcome of therapy-related myeloid neoplasms treated with azacitidine
Splice factor mutations in myeloid neoplasms, functional and clinical relevance
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
GATA2 deficiency and related myeloid neoplasms
Progression in Myeloid Neoplasms: Beyond the Myeloblast
Landscape of biallelic DNMT3A mutant myeloid neoplasms
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
Spitzoid Neoplasms: Suggestions from Genomic Aberrations
Current Challenges in the Characterization of Myeloid Neoplasms
Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasms
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
Formation of ultralong DH regions through genomic rearrangement
Outcome of therapy-related myeloid neoplasms treated with azacitidine
Splice factor mutations in myeloid neoplasms, functional and clinical relevance
International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
GATA2 deficiency and related myeloid neoplasms
Progression in Myeloid Neoplasms: Beyond the Myeloblast
Landscape of biallelic DNMT3A mutant myeloid neoplasms
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms
Spitzoid Neoplasms: Suggestions from Genomic Aberrations
Current Challenges in the Characterization of Myeloid Neoplasms
Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasms
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
Formation of ultralong DH regions through genomic rearrangement
Outcome of therapy-related myeloid neoplasms treated with azacitidine